tirzepatide nafld Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

These include: Liver Disorders: Conditions like hepatitis or cirrhosis can cause bilirubin (a liver byproduct) to build up in your urine, giving it a brown hue

Research Context Tirzepatide is a synthetic, lipidated 39-amino-acid polypeptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

Do not use it after the expiry date on the pack

Moreover, A double-blind study of patients with T2DM treated with metformin led to significant changes in the relative abundance of more than 80 bacterial species compared with placebo after 4 months, in which an increase in Escherichia and Akkermansia muciniphila and a decrease in Intestinibacter were also observed, whereas most of the changes with placebo occurred in phylum Firmicutes and phylum Proteobacteria (Wu et al., 2017)

However, the side effects using MT-2 are more common, but offsetting this is the fact that the darkening effect using MT-2 can be seen faster